Investigational drug · Phase 2
famzeretcel
Also called: human retinal progenitor cells, jCell
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Retinitis Pigmentosa.
Phase 2Last checked: Nov 20, 2026Latest source record: Jul 30, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
1
Any phase or sponsor naming "famzeretcel"
First trial start
2025
Jun 20, 2025
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "famzeretcel", any sponsor or status.
Conditions studied
As listed on its trial records.
- Retinitis Pigmentosa
Approved drugs for the same conditions: Ophthalmology
Largest trials
Live from ClinicalTrials.gov: studies naming "famzeretcel" as an intervention, largest first.
- Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)Active, not recruiting
jCyte, IncIndustry
NCT06912633 · 31 participants · Start Jun 20, 2025 · Primary completion Dec 2026
Drug: human retinal progenitor cells · For: Retinitis Pigmentosa
Sites: Phoenix, Arizona; Bakersfield, California; Beverly Hills, California · 12 sites in all
Newest research
PubMed records naming it or its code names, newest first.
- Mesenchymal stem cell-derived small extracellular vesicles enhance the therapeutic effect of retinal progenitor cells in retinal degenerative disease rats.
Ren C, Chen M, Ren B, et al. · Neural Regen Res 2026
- Human Retinal Progenitor Cell (hRPC) Migration in Three-Dimensional (3D) Environments of Varying Stiffness and Composition.
Zhao P, Kundu J, Blanton D, et al. · J Tissue Eng Regen Med 2025
- Dynamic molecular and cellular characteristics of VSX2-positive retinal progenitor cells in human retinal organoids.
Zheng D, Wang Y, Guan Y, et al. · Stem Cell Res Ther 2025
- 3D Printing of Chitosan Scaffolds and Films with Varying Roughness for Cultivation of Human Retinal Progenitor Cells.
Solberg A, Robles-Anda N, Pasquier E, et al. · ACS Omega 2025
- Chondrocytes Embedded in Agarose Generate Distinct Metabolic Heat Profiles Based on Media Carbon Sources.
Myers E, Brahmachary P, Mensah S, et al. · Ann Biomed Eng 2025
- Retinal progenitor cells (jCell) for retinitis pigmentosa.
Yang J, Kuppermann BD, Liao D, et al. · Front Cell Neurosci 2025
Also in development for Retinitis Pigmentosa
- BS01Phase 22 trials
Bionic Sight LLC · Retinitis Pigmentosa, Geographic Atrophy (GA) Secondary to Dry Age-related Macular Degeneration (AMD)
- CPK850Phase 21 trial
Novartis · Retinitis Pigmentosa
- KIO-301Phase 21 trial
Kiora Pharmaceuticals, Inc. · Retinitis Pigmentosa
- OCU400Phase 21 trial
Ocugen · Retinitis Pigmentosa, Leber Congenital Amaurosis
- SPVN06Phase 21 trial
SparingVision · Retinitis Pigmentosa
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.